Author:
Yue Wei,Fan Ping,Wang Jiping,Li Yuebai,Santen Richard J.
Subject
Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference38 articles.
1. The ATAC Trialists’ Group, Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomized trial, Lancet 359 (2002) 2131–2139.
2. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer;Goss;New Engl. J. Med.,2003
3. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen;Encarnacion;Breast Cancer Res. Treat.,1993
4. MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182.780;Brunner;Cancer Res.,1993
5. Changes in epidermal growth factor receptor expression and response to ligand associated with acquired tamoxifen resistance or oestrogen independence in the ZR-75-1 human breast cancer cell line;Long;Br. J. Cancer,1992
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献